Health & Fitness

According to FutureWise analysis the market for Ibuprofen API in 2023 was US$ 7.5 billion, and is expected to reach US$ 9.5 billion by 2031 at a CAGR of 3.5%. Ibuprofen is a white crystalline powder, with the chemical name 2-(4-isobutylphenyl) propionic acid and a molecular formula of C13H18O2. As the Active Pharmaceutical Ingredient (API) in ibuprofen, it is used to create various forms of the medication, including tablets, capsules, and syrups. This non-steroidal anti-inflammatory drug (NSAID) is effective for relieving pain, reducing fever, and decreasing inflammation.  Ibuprofen works by inhibiting the production of prostaglandins, which are chemical messengers responsible for causing pain, fever, and inflammation in the body. By lowering the levels of these chemicals, ibuprofen can help alleviate pain and reduce inflammation. It is available in both prescription and over-the-counter forms and is commonly used to treat a variety of conditions, including headaches, ... Continue reading →

The global topical atopic dermatitis treatment market is segmented into Drug Class, Distribution Channels, and Regions. The global market is projected account for USD 3,291.7 Mn in 2024 and to grow at a CAGR of 8.5% through 2032. The global market is poised for impressive growth, projected to expand by 1.63 times between 2024 and 2032, unlocking over USD 2.5 million in opportunities. This market is categorized by drug class, which includes brain topical JAK inhibitors, topical calcineurin inhibitors, topical PDE4 inhibitors, topical corticosteroids, and other therapies. Notably, topical JAK inhibitors are leading the charge, commanding nearly 31.6% of the market share in 2023 and boasting a robust CAGR of 9.8% through 2032. Exciting times lie ahead for this dynamic sector! FutureWise Market Research has instantiated a report that provides an intricate analysis of Topical Atopic Dermatitis Treatment Market trends that shall affect the overall market growth. Furthermore, it ... Continue reading →

According to FutureWise analysis the market for Hypoparathyroidism Treatment in 2023 was US$ 1.09 billion, and is expected to reach US$ 2.2 billion by 2031 at a CAGR of 8.5%. Hypoparathyroidism is an endocrine disorder characterized by insufficient production of parathyroid hormone (PTH) by the parathyroid glands, which are located in the neck. PTH plays a critical role in regulating calcium, phosphate, and calcitriol (the active form of Vitamin D) levels in the blood and bones. With hypoparathyroidism, the lack of PTH leads to decreased calcium levels and increased phosphorus levels in the body. Symptoms of this condition can include muscle cramps, twitching, spasms, and sensations of numbness or tingling in the fingers, toes, and around the mouth. Various factors can contribute to the development of hypoparathyroidism, including genetic mutations, autoimmune disorders, surgical interventions, radiation therapy, or damage to the parathyroid glands due to injury or infection. ... Continue reading →

According to FutureWise analysis the market for in vitro diagnostics in 2023 was US$ 121.38 billion, and is expected to reach US$ 176.89 billion by 2031 at a CAGR of 4.82%. Recent technological advancements in in-vitro diagnostic (IVD) techniques have significantly boosted the growth of the global IVD market. Key players are launching innovative diagnostic tools that are likely to drive further market expansion. For example, Qiagen is a leading provider of point-of-care molecular diagnostics, known for delivering highly accurate results tailored for individual patient care. Additionally, government initiatives and healthcare organizations have positively impacted market growth by increasing awareness and education around IVD tools and personalized treatments. These efforts have created exciting business opportunities in the field. However, it's important to note that the high costs associated with in-vitro treatments could present challenges in the future. As the demand for more ... Continue reading →

According to FutureWise analysis the market for Gaucher Disease Treatment in 2023 was US$ 2.1 billion, and is expected to reach US$ 2.51 billion by 2031 at a CAGR of 2.2%. Gaucher disease (GD) is a metabolic disorder that disrupts the recycling of cellular glycolipids, attributable to a deficiency in the lysosomal enzyme glucocerebrosidase (EC3.2.1.45), commonly referred to as glucosyl ceramidase or acid beta-glucosidase (GBA). In individuals diagnosed with GD, glucosylceramide, also known as glucocerebroside, along with several related compounds, accumulates within cell lysosomes due to impaired degradation processes that typically convert these substrates into glucose and lipid components. The management of Gaucher disease is tailored to each patient, taking into account the variability in the manifestations, severity, disease progression, and individual treatment response. Gaucher disease was the first inherited metabolic disorder to be addressed with enzyme ... Continue reading →

According to FutureWise analysis the market for Remote Patient Monitoring Software and Services in 2023 was US$ 11.32 billion, and is expected to reach US$ 111.01 billion by 2031 at a CAGR of 33.00%. Remote patient monitoring (RPM) is a healthcare delivery system that enables healthcare providers to assess a patient's health status and medical condition remotely using digital technologies. This process involves remote monitoring devices and software that collect and transmit patient data to healthcare providers for analysis. The software used in RPM offers real-time data on vital signs, medication adherence, and other health metrics, allowing healthcare providers to make informed decisions about patient care. The advantages of RPM include improved patient outcomes, reduced hospital readmissions, and increased patient engagement in their own health. Specialized telemedicine software serves as a bridge between caregivers and patients by providing a framework for ongoing ... Continue reading →

According to FutureWise analysis, the pharma track and trace solutions market was US$ 2.1 Billion in 2022 and is anticipated to grow at a CAGR of 9.6% from 2023 to 2031. The "pharma track and trace market" refers to the use of technologies and processes that help us keep track of medicines as they move through the supply chain, from manufacturing to distribution and sales. This approach not only helps prevent fraud but also ensures that the medicines are safe and genuine. Pharma track and trace (T&T) solutions assist companies in managing their supply chains and reducing the risks of counterfeit products. They allow for smooth transportation of goods, verify product identities, and help with logistics and packaging.Because of this, pharma T&T solutions are beneficial for both personal and business needs. They can save money on fuel and insurance, provide customer support, and send you important updates via SMS or email. One key driver is the increasing focus on ... Continue reading →

According to FutureWise analysis the market for seeg depth electrodes in 2023 was US$ 12.42 million, and is expected to reach US$ 16.38 million by 2031 at a CAGR of 3.50%. Stereo electroencephalography (SEEG) is an invasive surgical procedure designed to pinpoint the exact area of the brain where epileptic seizures originate. During this procedure, doctors implant electrodes at specific brain locations, which are subsequently monitored to accurately determine the source of the seizure. SEEG allows for improved localization at the onset of seizures, facilitating surgical excision and potentially leading to better outcomes for patients. The technique employs a stereotactic approach to implant multiple depth electrodes, enabling the recording of cortical and subcortical areas without the need for extensive craniotomies. Importantly, in the context of SEEG, the term "stereo" refers to the three-dimensional nature of the recordings obtained. To minimize complications, the ... Continue reading →

According to FutureWise analysis the market for histopathology services in 2023 was US$ 26.8 billion, and is expected to reach US$ 42.46 billion by 2031 at a CAGR of 5.92%. Histopathology involves the microscopic analysis of tissue anatomy to identify abnormalities. This service is used in clinical settings for the preliminary diagnosis of various medical conditions. It is crucial in clinical investigations to determine the pharmacology, toxicity, and effectiveness of medical therapies. Histopathology includes the on-site collection and processing of samples in order to identify tissue abnormalities by comparing them to healthy tissues. This field studies changes in tissue caused by disease or injury and serves as an essential diagnostic tool for healthcare professionals to detect and diagnose a wide range of diseases, including cancer. The histopathology market encompasses products and services related to the preparation, staining, and analysis of tissue samples. As the healthcare ... Continue reading →

According to FutureWise analysis the market for triple-negative breast cancer treatment in 2023 was US$ 0.63 billion, and is expected to reach US$ 0.86 billion by 2031 at a CAGR of 3.9%. Triple-negative breast cancer (TNBC) is a type of breast cancer that does not have estrogen receptors (ER), progesterone receptors (PR), or an excess of the HER2 protein. All three tests for these markers yield "negative" results. This form of cancer tends to affect women under the age of 40, particularly those who are Black or carry the BRCA1 mutation. TNBC is considered an aggressive type of cancer because it grows rapidly and is more likely to have spread by the time it is diagnosed. Additionally, it has a higher likelihood of recurrence after treatment compared to other breast cancer types. Most triple-negative tumors are classified as basal-like molecular subtypes, although the two terms are not entirely synonymous. Approximately 10-15% of all breast tumors are classified as ... Continue reading →